CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced it will participate in the following upcoming investor conferences.
| Event: | Deutsche Bank 40th Annual Health Care Conference | |||
| Date / Time: | Thursday, May 7, 2015 at 12:50 PM (EDT) | |||
| Location: | The InterContinental Hotel, Boston, Mass. | |||
| Event: | Bank of America Merrill Lynch 2015 Health Care Conference | |||
| Date / Time: | Tuesday, May 12, 2015 at 2:20 PM (EDT) | |||
| Location: | Encore at the Wynn Hotel, Las Vegas, Nev. | |||
| Event: | UBS 2015 Global Healthcare Conference | |||
| Date / Time: | Wednesday, May 20, 2015 at 10:30 AM (EDT) | |||
| Location: | Sheraton New York Times Square Hotel, New York, NY | |||
Live audio webcasts will be available on the “Events and Presentations” page in the Investors & Media section on the Company’s website (http://investor.acceleronpharma.com/events.cfm). A replay of the webcasts will also be available from Acceleron’s website.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta (TGF-ß) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and pre-clinical protein therapeutic candidates with novel mechanisms of action. These protein therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases. For more information, please visit www.acceleronpharma.com.
Contacts
Acceleron Pharma Inc.
Kevin F. McLaughlin, 617-649-9204
Senior Vice President and Chief Financial Officer
or
Media:
Suda Communications LLC
Maureen L. Suda, 585-387-9248
Help employers find you! Check out all the jobs and post your resume.
